Connect Biopharma Holdings Limited is a biotechnology company engaged in the development of novel antibody therapeutics to treat inflammatory and autoimmune diseases. With a focus on precision medicine, the company aims to revolutionize the treatment landscape by targeting specific immune pathways. Its innovative approach has the potential to bring about significant advancements in patient care and improve outcomes.
